PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Boston University Student Health Services, Boston, MA, USA. Electronic address: hnichols@bu.edu.\', \'National Emerging Infectious Diseases Laboratories, Boston, MA, USA; Bioinformatics Program, Boston University, Boston, MA, USA.\', \'Boston University Student Health Services, Boston, MA, USA.\', \'National Emerging Infectious Diseases Laboratories, Boston, MA, USA; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Bioinformatics Program, Boston University, Boston, MA, USA.\', \'National Emerging Infectious Diseases Laboratories, Boston, MA, USA; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Global Health, Boston University School of Public Health, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00840-710.1016/j.ijid.2021.10.053
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34757200
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34757200>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34757200>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all